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1. introduction 
Luteinizing hormone - releasing hormone (LH-RH) 
is a hypothalamic hormone which stimulates the se- 
cretion of pituitary hormone(s) which regulate 
ovulation [I] . The elucidation of the amino acid 
sequence (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg- 
Pro-Gly-NHz) of LH-RH [l] has enabled a consid- 
erable number of related peptides to be synthesized 
and examined for biological activities. Much data has 
accumulated on the structure-activity relationship of 
this hormonal peptide. The results of these studies 
suggested that the active site of LH-RI-l was located 
in the N-terminal region of the molecule, that is, the 
pGlu and the His residues played important roles in 
the hormonal activity [2-S]. Furthermore, studies 
on analogs of LH-RH lacking the N-terminal pGlu ring 
structure suggested that the CO-NHCHCO- group was 
the minimum necessary part of the pGlu residue to 
exhibit biological activity. Recently several analogs 
of LH-RH with enhanced LH and FSH releasing activi- 
ty were synthesized [6-lo] . Interest in derivatives 
of LH-RH has arisen, primarily, because of the possi- 
bility of finding analogs of LH-RH which would 
inhibit the release of gonadotropins instead of 
stimulating them. This may form the basis of a new 
contraceptive method. Part of the mechanism of 
action of LH-RH involves the interaction of the 
hormone with pituitary cell receptors [ 111, and the 
binding of LH-RH to the adenohypophysis could be 
located at the level of the plasma membrane [12-131 
An important criterion for an inhibitor of LH-RH 
actions would be that it should effectively compete 
with the hormone for pituitary receptor sites. We 
were therefore prompted to report on data concern- 
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ing our receptor studies with the peptide des-His-2- 
des-Gly-IO-LH-RH-ethylamide, which was shown to 
act as antagonist of LH-RH in vivo [ 141. 
2. Materials and methods 
LH-RH, 12sI-labeled LH-RI-I and des-His-2-des- 
Gly-lo-LH-RI-I-ethylamide were obtained from 
Farbwerke Hoechst AG, Frankfurt, GFR. The 
specific activity of [ ‘*‘I] LH-RH used in the present 
experiments was 241 mCi/mg. Specific biological 
activity of ‘*’ I-labeled LH-RI-I was indistinguishable 
from unlabeled material. Female rats of the Sprague 
Dawley strain (Mus Rattus AG, Brunnthal, GFR) 
weighing 17.5-200 g were used for all experiments. 
The animals were housed in a temperature-controlled 
room lighted for only 12 hr a day and unrestricted 
access was provided to food and water. The rats 
were killed by decapitation, the posterior lobes of the 
pituitaries were removed and the anterior pituitaries 
cut in halves. Five halves were transferred aseptically 
into 25 ml Erlemneyer flasks, which contained 2 ml 
of sterile medium. The incubation medium consisted 
of 9 parts Medium 199 (Biocult Labs., Glasgow) 1 
part fetal bovine serum (Reheis Chemical Comp., 
Chicago) and 50 U/ml each of penicillin and strepto- 
mycin were added to reduce bacterial contamination. 
The opposite halves of the anterior lobes of the 
pituitaries served as controls and were treated in the 
same manner. All incubations were Larried out at 
37°C under an atmosphere of 95% air and 5% CO*. 
Pre-incubation of the glands was performed for 1 hr. 
The medium was changed and incubation was con- 
tinued for 4 hr. New medium contained LH-RH 
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(10 ng/ml) and/or des-His-2-des-Gly- 1 O-LH-RH- 
ethylamide at concentrations of 0.1,.5, 10, 100 and 
1000 ng/ml medium. The controls were incubated 
in the absence of peptides. Five incubation flasks 
were set up for the experimental and control groups. 
After incubation the media were snap frozen and 
stored at - 25°C. The pituitaries were washed twice 
with buffer (0.01 M phosphate, 0.15 M NaCl, 0.1% 
NaNa) and snap frozen in 2 ml of the same buffer. 
Pituitary protein was determined according to Lowry 
et al. [ 151 . Media were assayed for LH and FSH by 
radioimmunoassay as described by Niswender et al. 
[ 161. The separation of bound from free tracer was 
modified by using a solid-phase second antibody 
(Dasp, anti-rabbit, N.V. Organon, Oss, Holland). 
Data were analysed by Student’s paired t-test. 
Plasma membranes of adenohypophyses were 
prepared according to previously described procedures 
[ 171. Plasma membranes were suspended in Hepes 
buffer (mM: NaCl, 137; KCl, 5; NasHPO,, 0.7; 
N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic 
acid, 25; MgCla, 5; sucrose, 300; pH 7.2). Concen- 
trations of plasma membrane fractions are reported 
as protein content [ 151 . 
The [ ‘*‘I] LH-RH binding assay was carried out 
at 4°C. AI1 solutions were made up in Hepes buffer. 
Aliquots of plasma membranes (111 pg protein) 
were mixed with various concentrations of LH-RH 
and des-His-2-des-Gly- 1 0-LH-RH-ethylamide, 
and incubated for 30 min. [1251] LH-RH (323.2 
pmoles) was added and incubation continued for 
another 30 min. Final incubation volume was 80 ~1. 
The reaction was stopped by adding a IO-fold excess 
of ice cold phosphate buffer (0.01 M phosphate, pH 
7.2), and the incubation mixtures were immediately 
filtered through a cellulose acetate filter (EHWP 
02500, Millipore Corp., Bedford, Mass. 01730, USA). 
The falters were washed three times with 2 ml of the 
same phosphate buffer. Binding assays were carried 
out in triplicates. 
Analysis of binding data was performed by Scat- 
chard plot analysis [ 181 by a computer program 
LW-RI4 
# 252 
DES-HIS-Z-DfS-GLV-ID-LU-RCI-ETHYLAMIDE 
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Fig. 1. Binding of [Ia5 I] LH-RH to the pituitary plasma membrane as function of the concentration of unlabeled LH-RH and 
octapeptide antagonist. Means * SD of three determinations. 
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(unpublished) and was run on a PDPg/e (Digital 
Equipment Corp., Maynard, Mass., USA). 
3. Results and discussion 
Recently LH-RH interaction with the pituitary 
plasma membrane was described [ 12-131 and 
found to be a temperature, cation and pH dependent 
process [ 191. Furthermore, LH-RH binding to its 
pituitary receptors was shown to be a rapid and 
reversible reaction [ 12,201 . In addition, two popu- 
lations of binding sites with an apparent affinity con- 
stant of approx. 2 X 10-s M and 2 X 10z7 M were 
observed [ 131 . LH-RH interaction was found to be a 
highly specific process [ 12,201 and analysis of binding 
data obtained from experiments with analogs suggested 
proportionality between releasing ability and receptor 
affinity [21]. Similarily, TRH binding sites were 
reported to have affinities for TRH analogs which are 
proportional to their biological potencies [22] . 
Des-His-2-des-Gly- IO-LH-RH-ethylamide was 
found to compete with [ ’ 2s I] LH-RH for LH-RH 
binding stes (fig. 1). Relative binding at all compet- 
ing concentrations of the LH-RH analog studied 
was parallel to that obtained at equivalent LH-RH 
concentrations. Similarity in the kinetics of binding 
16 
- 0 LU-RH 
yc 
0 WS-HIS-2-DES-GLY-IO-LH-RH-ETCIYLIMIDE 
12 
0 LH-RH *252 
0 (DEs-HI~*-DEs-cLv~) LU-RH 
Fig. 2. Analysis of competition data of fig. 1 by Scatchard 
plot. 
data are exemplified by Scatchard and reciprocal 
plots (figs. 2 and 3). In such analysis it is seen that 
des-His-2-des-Gly- IO-LH-RWethylamide is truly 
competitive for the LH-RH receptor. The affinity of the 
analog for the receptor is the same as that of LH-RH 
as evidenced (fig. 1) by the concentrations of LH-RH 
and its analog required to 50% compete for saturating 
amounts of bound [’ 2s I] LH-RH [23,24] . Because 
of these data previous assumptions [21,25] no longer 
+ 252 0 
/ 
Fig. 3. Analysis of binding data of fig. 1 by double reciprocal plot. 
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Table 1 
LH and FSH release of adenohypophyses in vitro in the absence and presence of 
LH-RH and for des-His-2_des_Gly-lo-LH-RH-ethylamide. Data are means t; SD of 
five determinations and are expressed in terms of NIAMD-Rat LH-RP-1 and 
NIAMD-Rat FSH-RP-1 
LH-RH 
(nglml) 
analog 
(nglml) 
p”g LHlml 
f SD 
p vs. control c(g FSH/ml 
r SD 
p vs. control 
- - 12.3 f 0.8 1.2 + 0.2 
10 - 24.7 f 1.8 < 0.005 3.3 + 0.4 < 0.005 
- 1000 15.5 f 1.7 NS 1.5 f 0.3 NS 
- 100 13.2 f 1.1 NS 1.8 t 0.1 NS 
- 10 12.9 * 1.2 NS 2.0 * 0.2 NS 
- 5 15.5 * 2.0 NS 1.7 f 0.2 NS 
- 0.1 12.7 * 1.3 NS 1.2 * 0.1 NS 
10 1000 16.3 i 1.5 NS 1.5 k 0.1 NS 
10 100 18.0 f 0.3 NS 2.5 * 0.4 < 0.05 
10 10 17.4.k 1.3 NS 2.8 f 0.1 < 0.025 
10 5 28.2 f 1.7 < 0.005 4.0 f 0.3 < 0.005 
hold that the histidyl residue in the LH-RH molecule 
is critical for the recognition of the hormone by its 
receptor. 
Des-His-2-des-Gly-IO-LH-RH-ethylamide possessed 
only negligible releasing activity, and blocked LH-RH 
stimulated LH and FSH release (table 1). The competib 
tive antagonism of the octapeptide to LH-RH and the 
lack of gonadotropin releasing activity of the analog at 
concentrations tenfold higher than that required to 
suppress the response to LH-RH indicate dissociation 
of the binding and secretory process. Our data are in 
agreement with the previous observation that intracarotid 
infusion of the octapeptide antagonist effectively 
blocked responses to subsequent intravenous injec- 
tions of LH-RI-I [ 141. Also, des-His-2-LH-RH was 
reported to inhibit secretion of LH by rat anterior 
pituitary cells in vitro [25]. It is noteworthy that 
another des-histidine peptide, des-His-1-glucagon, is a 
competitive antagonist of glucagon [26] . 
the processes which transmit the binding of LH-RI-l to 
gonadotropin release. An alternative explanation 
invokes the concept of cooperative interactions [27] 
between LH-RI-I binding sites. According to a model 
reported previously [28] our results could mean that 
the LH-RI-I receptor site and the elements mediating 
the secretory process can exist in two forms in 
equilibrium. A secretion-triggering and a resting 
state. LH-RH would then have preferential affinity 
for the secretory state. The antagonism of the analog 
could be a consequence of interaction and stabiliza- 
tion of the LH-RI-I receptor in the inactive resting 
configuration. But, further work is necessary to 
obtain more information on LH-RH-receptor inter- 
actions. 
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